ASX:BIOHousehold & Personal ProductsPersonal Care Products
Biome Australia Ltd
$0.275
Day Range
$0.265 – $0.275
52 Week Range
$0.200 – $0.630
Volume
129.17K
Avg Volume (10D)
500.86K
Market Cap
$62.70M
P/E Ratio
280.61
Price Chart
Market Statistics
Open$0.275
Previous Close$0.275
Day High$0.275
Day Low$0.265
52 Week High$0.630
52 Week Low$0.200
Valuation
Market Cap62.70M
Shares Outstanding228.00M
P/E Ratio (Annual)280.61
P/E Ratio (TTM)65.48
Price to Book10.10
Trading Activity
Volume129.17K
Value Traded35.03K
Bid$0.265 × 55,903
Ask$0.275 × 3,599
Performance
1 Day1.85%
5 Day1.85%
13 Week-29.49%
52 Week-40.22%
YTD-34.52%
Technical Indicators
RSI (14)51.40
50-Day SMA$0.293
200-Day SMA$0.400
Latest News
Biotechnology
Biome Australia to Commence Domestic Production of Activated Probiotics Range
Biome Australia moves to onshore production of Activated Probiotics, targeting margin rise from 61% toward 65%+ as inventory and lead times shrink.
Biotechnology
Biome Australia Extends Exclusive Probiotical Supply Agreement Through 2028
Biome Australia extends exclusive Probiotical supply to 2028, securing supply amid expansion; H1 FY2026 revenue $12.4m, EBITDA-positive.
Biotechnology
Biome Australia Surges with 41% YoY Revenue Growth in Q2 FY26
Biome Australia (ASX: BIO) has reported a robust Q2 FY26, with revenue surging 40.9% year-on-year to $6.48 million, significantly exceeding expectations and reinforcing its trajectory towards its 'Vis
Biotechnology
Biome Australia Launches First Human Clinical Trial on Proprietary BMB18 Strain
Biome Australia (ASX: BIO) has submitted ethics approval and registered its first human clinical trial on proprietary probiotic strain Lactobacillus plantarum BMB18 with the Australia New Zealand Clinical Trials Registry.